Consolidated Statement Of Cash Flows

Immuno-Biological Laboratories Co., Ltd. - Filing #7717736

Concept 2018-04-01 to
2018-09-30
As at
2018-09-30
As at
2018-03-31
2017-04-01 to
2017-09-30
As at
2017-09-30
As at
2017-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-41,180,000 JPY
-38,213,000 JPY
Impairment losses
8,255,000 JPY
576,000 JPY
Interest and dividend income
-638,000 JPY
-637,000 JPY
Interest expenses
710,000 JPY
966,000 JPY
Foreign exchange losses (gains)
-4,161,000 JPY
-632,000 JPY
Subtotal
-88,536,000 JPY
58,069,000 JPY
Decrease (increase) in trade receivables
34,961,000 JPY
27,616,000 JPY
Income taxes paid
-3,926,000 JPY
-3,337,000 JPY
Decrease (increase) in inventories
-34,034,000 JPY
-11,902,000 JPY
Net cash provided by (used in) operating activities
-92,500,000 JPY
54,441,000 JPY
Increase (decrease) in trade payables
-4,222,000 JPY
3,455,000 JPY
Other, net
-29,244,000 JPY
238,000 JPY
Interest and dividends received
635,000 JPY
634,000 JPY
Interest paid
-673,000 JPY
-925,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
JPY
-900,000 JPY
Net cash provided by (used in) investing activities
-9,876,000 JPY
-9,900,000 JPY
Other, net
-876,000 JPY
JPY
Cash flows from financing activities
Proceeds from long-term borrowings
30,000,000 JPY
JPY
Net increase (decrease) in short-term borrowings
10,000,000 JPY
JPY
Repayments of long-term borrowings
-91,044,000 JPY
-73,044,000 JPY
Net cash provided by (used in) financing activities
-52,739,000 JPY
-73,358,000 JPY
Other, net
-1,695,000 JPY
-314,000 JPY
Effect of exchange rate change on cash and cash equivalents
4,161,000 JPY
632,000 JPY
Net increase (decrease) in cash and cash equivalents
-150,954,000 JPY
-28,184,000 JPY
Cash and cash equivalents
2,299,921,000 JPY
2,450,875,000 JPY
2,493,918,000 JPY
2,522,102,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.